1. Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Saterlee W, Raber MN, Plunkett W (1990) A phase I clinical, plasma and cellular pharmacology study of 2?, 2?-difluorodeoxycytidine. J Clin Oncol (in press)
2. Chou T-C, Arlin Z, Clarkson BD, Philips FS (1977) Metabolism of 1-?-d-arabinofuranosylcytosine in human leukemic cells. Cancer Res 37: 3561?3570
3. Estey E, Keating MJ, McCredie KB, Freireich EJ, Plunkett W (1990) Cellular ara-CTP pharmacokinetics, response, and karyotype in newly diagnosed acute myelogenous leukemia. Leukemia 4: 95?99
4. Gandhi V, Plunkett W (1990) Modulatory activity of 2?, 2?-difluorodeoxycytidine on the phosphorylation and cytotoxicity of arabinosyl nucleosides. Cancer Res 50: 3675?3680
5. Grunewald R, Kantarjian H, Keating MJ, Abbruzzese J, Tarasoff P, Plunkett W (1990) Pharmacologically directed design of the dose rate and schedule of 2?, 2?-difluorodeoxycytidine administration in leukemia. Cancer Res 50: 6822?6826